Host: Lee Freedman, MD

Guest: Ramesh Rengan, MD, PhD

Because the lungs are particularly sensitive to radiation, treating lung cancer can be challenging. What’s the current standard of care for the management of inoperable non-small cell lung cancer, and how might proton therapy benefit patients with this condition? How does the efficacy of proton therapy for lung cancer compare to other therapies? Dr. Ramesh Rengan, assistant professor of radiation oncology at Penn Medicine, evaluates the potential of proton therapy for lung cancer. Dr. Lee Freedman hosts. Produced in Cooperation with